In Re Vitamins Antitrust Litigation

398 F. Supp. 2d 209, 2005 WL 2716278
CourtDistrict Court, District of Columbia
DecidedOctober 24, 2005
Docket99-197 (TFHJMF)
StatusPublished
Cited by11 cases

This text of 398 F. Supp. 2d 209 (In Re Vitamins Antitrust Litigation) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Vitamins Antitrust Litigation, 398 F. Supp. 2d 209, 2005 WL 2716278 (D.D.C. 2005).

Opinion

*213 MEMORANDUM OPINION

FACCIOLA, United States Magistrate Judge.

This case was referred to me for the resolution of Chitwood & Harley’s Motion for Court Assistance in Allocating the Court’s Attorneys’ Fee Award Among Plaintiffs’ Counsel. Upon consideration of the motion, opposition, and the evidence introduced during two phases of an eviden-tiary hearing, the motion is granted in part and denied in part. Also ripe and ready for consideration are two additional motions. For the reasons stated herein, Cohen, Milstein, Hausfeld & Toll’s Motion to Dismiss for Failure to State a Claim is denied and Cohen, Milstein, Hausfeld & Toll’s Motion to Strike Chitwood & Harley’s Statement Regarding Reference to Magistrate Judge in Connection with May Ip, 200Jp Status Conference and for Sanctions is denied.

I. MOTION FOR ASSISTANCE ALLOCATING FEE AWARD

A. Brief Overview

In early 1997, Boies Schiller and a group of law firms began investigating the bulk vitamins industry by interviewing witnesses and conducting research regarding the major bulk vitamins manufacturers. Other firms also began investigations in late 1997 and early 1998. As a result of these investigations, many firms began filing lawsuits in various districts across the country. In March 1999, the United States Department of Justice announced that some of the defendants identified in these lawsuits had agreed to plead guilty to antitrust violations. Two months later, two major defendants pled guilty or agreed to plead guilty for fixing the price of vitamins; as part of their plea agreements, one defendant agreed to pay $500 million in criminal fines, and the other agreed to pay $225 million-the largest criminal fines ever obtained by the Justice Department.

Both before and after the announcement of the guilty pleas and fines, plaintiffs’ counsel engaged in a series of negotiations with the defendants. Despite the fact that liability was not an issue, the negotiations proved arduous. Ultimately, the parties reached a settlement wherein defendants agreed, among other things, to pay plaintiffs’ counsel over $123 million in attorneys’ fees. On July 16, 2001, Chief Judge Hogan approved plaintiffs’ petition for attorneys’ fees and awarded class counsel $123,188,032.00 for work performed in relation to the settlement agreement resolving the antitrust claims.

In order to distribute the fee awarded by Judge Hogan, Co-Lead Counsel agreed to divide the total fee into three pools. All 57 firms, including C & H, ratified this decision.

Each pool was headed by one of the three Co-Lead Counsel. Susman Godfrey alone constituted one pool and received 10 percent of the fee. Boies Schiller’s group received 54 percent of the fee, and all of the firms within that group agreed upon *214 the allocation that Boies Schiller made. Cohen, Milstein, Hausfeld & Toll (“CMHT”) and its group received 36 percent of the fee awarded by Judge Hogan. Within that pool, all of the firms accepted the allocation that was made for them with the exception of Chitwood & Harley (“C & H”). However, 1 instead of requesting that its fee award be reconsidered by the full 13-member Executive Committee, C & H filed its Motion for Court Assistance in Allocating the Court’s Attorneys’ Fee Award Among Plaintiffs’ Counsel. This fee dispute was referred to me for final resolution.

I have thoroughly considered the arguments of each firm, the hearing transcripts from both Phase I and Phase II of the Evidentiary Hearing, the exhibits introduced therein, and the pleadings filed in relation to this matter. In this Opinion, I summarize my findings of fact, articulate the standard of review applicable to this dispute, and analyze the facts in light of that standard. I conclude that, because of the errors made by CMHT in distributing the fee award within its pool, C & H is entitled to some additional money, but not the amount that it has suggested to the court.

B. Findings of Fact

1. Beginning in the spring of 1997, attorneys that would later prosecute this action discovered and investigated a conspiracy involving antitrust violations, price fixing, and allocation of customers among manufacturers of bulk vitamins. These firms, led by Boies Schiller, filed the first lawsuits against the manufacturers, and Boies Schiller met with the Department of Justice to disclose information it had uncovered.

2. In late 1997, CMHT began its own investigation of the conspiracy among vitamins manufacturers. CMHT also hired an expert to perform an economic analysis of the vitamins industry. In early 1998, C & H also began investigating the conspiracy claims.

3. On March 2, 1999, the United States Department of Justice issued a press release stating that a Swiss vitamins manufacturer and five United States executives had agreed to plead guilty and cooperate with the government’s ongoing investigation of illegal collusive practices in the international vitamins industry.

4. Two months later, two defendants agreed to plead guilty and pay a total of $725 million in criminal fines. At that point, it became clear that liability would not be a difficult issue in the civil case.

5. On May 27, 1999, this court approved the Stipulated Pretrial Case Management Order No. 2 (“Case Management Order”) naming Boies Schiller, CMHT, and Susman Godfrey as Co-Lead Counsel. These three firms, in addition to C & H and Bain-bridge & Straus, were appointed to the Steering Committee. Other firms were appointed to other committees, but Co-Lead Counsel and the Steering Committee occupied the top two tiers in the organizational structure of plaintiffs’ class counsel. Thus, the order described the organization of class counsel as follows:

Co-Lead Counsel CMHT Susman Godfrey Boies & Schiller

Steeling Committee All 3 Co-Lead Counsel firms Bainbridge & Straus C&H

Executive Committee 8 other firms

Discovery Committee 3 other firms

Experts Committee 3 other firms

*215 Briefing Committee 2 other firms

Investigations Committee 3 other firms

6. Before submitting the proposed order to the court, the Case Management Order-and the organizational structure established therein-had been agreed upon by all of plaintiffs’ counsel. As the firm that had initiated the investigation and led the original group of firms in prosecuting various lawsuits, Boies Schiller naturally assumed the role of Co-Lead Counsel. Susman Godfrey received a Co-Lead Counsel position because of the reputation and skill of Steven Susman (“Susman”) as a trial attorney and because the firm had filed a lawsuit in Texas, which was one of the locations that was considered a highly likely place for the case to proceed given the pending grand jury investigation in Texas.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cobell Ex Rel. Cobell v. Jewell
260 F. Supp. 3d 1 (District of Columbia, 2017)
Romero v. ITW Food Equipment Group LLC
118 F. Supp. 3d 349 (District of Columbia, 2015)
Tadayon v. Greyhound Lines, Inc.
District of Columbia, 2012
In Re: High Sulfur
Fifth Circuit, 2008
In Re High Sulfur Content Gasoline Products Liab.
517 F.3d 220 (Fifth Circuit, 2008)
Silvestri v. Barrett
517 F.3d 220 (Fifth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
398 F. Supp. 2d 209, 2005 WL 2716278, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-vitamins-antitrust-litigation-dcd-2005.